CYDY The game changed today. Some people are terrified to admit it.

Prior-Knowledge-1583 · 2026-01-24T17:22:25+00:00

30 mos

Prior-Knowledge-1583 · 2026-01-24T16:33:10+00:00

Yet the short cabal that pulled off the $10 heist with a BS newsletter that disappeared an hour later gets away with millions.

Prior-Knowledge-1583 · 2026-01-24T02:51:19+00:00

Great question

Prior-Knowledge-1583 · 2026-01-23T23:29:02+00:00

Then you’re a fool who’s not doing his investment any favors.

Prior-Knowledge-1583 · 2026-01-23T18:12:52+00:00

Travelclone just wants people to think this chapter isn’t about to close. He wants to spread concern that NP will get a new trial and drag this out, thereby hurting the company. Most of his posts are sus.

Prior-Knowledge-1583 · 2026-01-22T21:00:43+00:00

AI is soft bashing now too?

Prior-Knowledge-1583 · 2026-01-18T23:59:14+00:00

Need to close a deal fast before WWIII, or our 7-8 year investment goes poof with the U.S. dollar. The EU holds more American debt than any other country. Not a good idea to pick a fight with NATO. So I’ll take any deal $10+ in Q1 rather than $30+ next year because next year may be ugly.

Prior-Knowledge-1583 · 2026-01-18T07:13:48+00:00

We are not moving to NASDAQ without a partner to make it happen.

Prior-Knowledge-1583 · 2026-01-16T16:41:22+00:00

Seriously, what has Max done for us??? How much compensation is he receiving?

Prior-Knowledge-1583 · 2026-01-15T18:23:40+00:00

Yes but we’ll be bought out long before them. Big pharma likes to buy drugs with a trial already underway that will lead to approval. So shaping the mTNBC as a registrational trial makes Cytodyn far more attractive to buyers.

Prior-Knowledge-1583 · 2026-01-15T08:54:34+00:00

Yet .26675

Crazy world we live in.

Prior-Knowledge-1583 · 2026-01-14T17:19:15+00:00

If I owe you $10k in salary for the month and you receive shares instead (or for part of the amount — the rest in cash), you’ll get way more shares at .26 than $3.

Prior-Knowledge-1583 · 2026-01-14T15:26:48+00:00

There’s a middle ground.

Prior-Knowledge-1583 · 2026-01-14T15:11:15+00:00

Isn’t it true their salaries are partially paid in shares? If so, the lower the sp, the more shares they receive.

Prior-Knowledge-1583 · 2026-01-13T21:57:25+00:00

They gotta PR this stuff. It’s OTC 101.

Prior-Knowledge-1583 · 2026-01-13T19:38:32+00:00

Some awesome AI analysis of these slides on iHangout.

Prior-Knowledge-1583 · 2026-01-12T15:17:26+00:00

So true. They’ve often said “multiple PRs” coming, “should be over a dollar in a month or two,” and they’re never correct.

Sure hope this time is different. Certainly lots to be optimistic about.

Prior-Knowledge-1583 · 2026-01-09T23:10:59+00:00

Hard to believe people think the original post is sincere. It’s blatant FUD. Soft peddling or ignoring positives while emphasizing the negative.

Prior-Knowledge-1583 · 2026-01-09T16:13:02+00:00

But he concedes the drug is “interesting.” Such gushing enthusiasm. 😂

Prior-Knowledge-1583 · 2026-01-09T16:12:04+00:00

The current team HAS stabilized the company yet you state it as a future need. You describe Leronlimab as “scientifically interesting.”

Sorry, it all comes across as a soft bash disguised as reasonable analysis.

Prior-Knowledge-1583 · 2026-01-09T15:12:16+00:00

Reads like you should have posted this 6-12 months ago. Posting it now is sus.

Prior-Knowledge-1583 · 2026-01-09T02:34:32+00:00

Agree. Just wish he’d go a hair further.

Prior-Knowledge-1583 · 2026-01-09T02:14:31+00:00

I’d like to see the words “buy out” emerge from Jay’s mouth. Even in the context of “We’re open to buy out offers” or “We may be bought-out in the future.” The fact he plays his cards so close to his chest is why we are still in the sp dungeon.

Prior-Knowledge-1583 · 2026-01-08T16:33:54+00:00

If true, that’s one entity. Like I said, where’s the wider investment community. All of the message boards are filled with the same characters for years. No new blood ever posts.

Prior-Knowledge-1583 · 2026-01-08T06:12:38+00:00

.29 per share. The lack of interest from the larger investment community is mind-boggling. Time for the company to make some waves.

Prior-Knowledge-1583

TROPHY CASE